Physician profile
Anna Gallagher
NPI 1336773332
$1,398.94
in general payments reported to CMS, 2019-2025
7 companies · $498 in 2025
The $498 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.94 · 2022: $116 · 2023: $499 · 2024: $233 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $569.72 | 2021-2025 | Livdelzi, Epclusa |
| Fujifilm Healthcare Americas Corporation | $205.73 | 2023 | Utaswako Afp-L3 |
| Boston Scientific Corporation | $184.69 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Madrigal Pharmaceuticals | $156.56 | 2025 | Rezdiffra |
| Hologic Sales and Service, LLC | $147.45 | 2023 | Aptima |
| Abbvie INC. | $115.87 | 2022 | |
| Intercept Pharmaceuticals, INC. | $18.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.